Some others may choose to elaborate further, but was a pretty short and sharp meeting.
Biggest take away for me is that Vince and the board don't really seem concerned about the SP or the latest results. They feel that the manufacturing issues have already been sorted out over the last two years, so they dont really need to address these now.
Seemed like they were just focused on moving forward and that PH3 approval would be fairly routine by the FDA in due course largely due to safety.
AD results due Q1 next year are potentially ahead of schedule and these could potentially be much bigger the ACNE product for the company.
Upcoming AGM, page-27
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.5¢ |
Change
-0.020(5.48%) |
Mkt cap ! $543.4M | |||
| Open | High | Low | Value | Volume |
| 35.5¢ | 35.5¢ | 34.0¢ | $4.566M | 13.13M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 410003 | 34.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 35.0¢ | 346713 | 8 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| BOT (ASX) Chart |